REG - ConvaTec Group PLC - Appointment of Joint Corporate Brokers <Origin Href="QuoteRef">CTEC.L</Origin>

ConvaTecAnnouncement

16/01/2017 12:15

RNS Number : 2692U
ConvaTec Group PLC
16 January 2017
 PRESSRELEASE
Appointment of Joint Corporate Brokers 
READING, UNITED KINGDOM (16 January 2017) - ConvaTec Group Plc ("the Company"), a leading global medical products and technologies company, is pleased to announce the appointment of Goldman Sachs International and UBS Investment Bank as the Company's joint corporate brokers, with immediate effect.
About ConvaTec 
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com. 
Enquiries
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Rebecca Fitchett, Finsbury  +44 (0)207 251 3801
Goldman Sachs International+44 (0)20 7774 1000
William Smiley
Phil Raper
UBS Investment Bank +44 (0)20 7567 8000
Craig Calvert
Christopher Smith

This information is provided by RNS
The company news service from the London Stock Exchange
  END
APPBDGDBDBBBGRL